T-helper lymphocyte subsets and T cell activation in peripheral blood of children with juvenile idiopathic arthritis and arthralgias caused by other conditions
DOI:
https://doi.org/10.5457/ams.v43i1%20-%202.324Keywords:
JIA, CD3 CD4 CD45RA , CD3 CD4 CD45RO , activated T-cellsAbstract
Introduction: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. It encompasses a group of clinically heterogeneous arthritides that begin before the age of 16, and persist for more than 6 weeks. JIA often begins with pain in a joint and febrile condition, therefore it's very important to distinguish it from diseases with similar presentations.
Aim of this study was to examine and determine T-helper lymphocyte subsets CD4+CD45RA+, CD4+CD45RO+ and activated T-cells in peripheral blood of children with JIA and arthralgias caused by other conditions.
Patients and methods: Retrospective study included 40 patients with JIA and 40 patients with arthralgias caused by other conditions. Lymphocytes quantification was performed with Beckman-Coulter FC-500 cytometer.
Results: There was no statistical difference in the percentage of T-helper lymphocytes between children with JIA and children with arthralgias caused by other conditions (36.3±9.1:39.2±7.8; p>0,05). Also, percentage of CD4+CD45RA+ T-lymphocytes (20.5±8.3:23.2±7.2; p>0,05), and CD4+CD45RO+ T-lymphocytes were not different between two examined groups (15.7±4.9:15.9 ± 6.0; p>0,05).
Decrease in the ratio of CD4+CD45RA+T/CD4+CD45RO+T in patients with JIA in comparison with those in children with arthralgias caused by other conditions is significant (15:6; p=0,04). Concerning T-cell activation, measured as HLA DR expression, we find significant difference between children with JIA and children with arthralgias caused by other conditions (2.04±0.8:1.6±0.7; p=0,01).
Conclusion: Although there are clinical similarities between the JIA and arthritides caused by other reasons those two entities appear to be distinct phenotypically in expression of CD45 isoforms on T-helper lymphocytes and proportion of activated T-cells.
Published
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
